Figure 1.

Rates of sexual dysfunction (broken down by mean A1C) at baseline and in those with depression remission to BU. At baseline, no differences in sexual dysfunction were seen based on A1C after therapy; however, those with higher A1C levels had greater rates of sexual dysfunction, irrespective of depression remission to BU therapy. Whereas improvement in sexual functioning was greatest in those who experienced MDD remission and lower A1C levels, it was also observed in some subjects who did not achieve remission or who had persistently elevated A1C levels. Sexual dysfunction was determined using an SES score <5.